Læknablaðið

Volume

Læknablaðið - 15.01.2005, Page 114

Læknablaðið - 15.01.2005, Page 114
1 985-1 994 / ÁH/ETTUÞÆTTIR KRANSÆÐASJÚKDÓMA 11. Cox DR. Regression models and life tables. J Stat Soc 1972; 34 (Series B): 187-220. 12. Castelli WR The epidemiology of coronary heart disease. The Framingham study. Am J Med 1984; 76:4-12. 13. Stamler J, Wenthworth D, Neaton JD (for the MRFIT Research Group). Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Finding in 356.222 primary screenes of the Multiple Risk Factor Intervention Trial /MRFIT). JAMA 1986; 256:2823- 8. 14. Shaper AG, Pocock SJ, Walker M, Cohen NM, Whale CJ, Thom- son AG. British Regional Heart Study: Cardiovascular risk fac- tors in middle-aged men in 24 towns. BMJ 1981; 283:179-86. 15. Carlson LA, Böttiger LE. Risk factors of ischemic heart dis- ease in men and women. Results of the 19-year follow-up of the Stockholm prospective study. Acta Med Scand 1985;218: 207-11. 16. Keys A, ed. Coronary heart disease in seven countries. Circula- tion 1970; 41-42/Suppl. 1:1-211. 17. Woolf N. Pathology of atherosclerosis. Br Med Bull 1990; 46: 960-85. 18. The Lipid Research Clinics Coronary Primary Prevention Trial Results I. Reduction in incidence of coronary heart disease. Lip- id Research Clinics Program. JAMA 1984; 251: 351-64. 19. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerois and coro- nary venous bypass grafts. JAMA 1987; 257: 3233-40. 20. Bush TL, Fried LP, Barett-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin Chem 1988; 34: B60- B70. 21. Corrao JM, Becker RC, Ockene IS, Hamilton GA. Coronary heart disease risk factors in women. Cardiology 1990; 77/Suppl. 2: 8-24. 22. Welin L, Larson B, Svardsbudd K, Eriksson H, Wilhelmsen L, Tibblin G. Triglyserider, en kontroversiell riskfactor för hjárt- infarkt. Nya syn fra studien „1913 árs man“. Stockholm: Svenska Lákarsállskapets Riksstámma 1988; Sammanfattningar, 185-6. 23. Castelli WP. The trioglyceride issue: A view from Framingham. Am Heart J 1986; 122:432-7. 24. Sigurðsson G, Baldursdóttir Á, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfússon N. Predictive value of coronary artery disease in men. Am J Cardiol 1992; 69:1251-4. 25. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myo- cardinal infarction among women who stop smoking. N Engl J Med 1990; 332:213-21. 26. Medical Research Council Working Party: MRC trial of treat- ment of mild hypertension: principal results. BMJ 1985; 292: 97- 104. 27. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham study. Circulation 1986; 61: 1179-82. 28. Zanchetti A. Diastolic, systolic and 25 hour blood pressure: Which should be treated? International Society of Hypertension 1988, Hypertension Annual; 1988:3-19. 29. Holme I. Drug treatment of mild hypertension to reduce the risk of CHD: Is it worth-while? Stat Med 1988; 7:1109-20. English summary The Reykjavík Study 1967-1985: Risk factors for coro- nary heart disease mortality have been investigated in a prospective study of 8001 randomly selected lcelandic men and 8468 women. The men were aged 34-64 and the women 34-76 at the time of their first examination. After followup from 2-17 years 1140 (14.2%) of the men and 537 (6.3%) of the women had died. Coronary heart disease accounted for 43% of the mortality among the men, cancer 27% and cerebrovascular disease 7%. This distribution is in contrast to what was found among the women. Coronary heart disease accounted for 19.4% of the mortality, cancer 42.3% while the relative contribu- tion of cerebrovascular mortality was similar. The effects of various factors were assessed simultaneously with multivariate survival analysis using the Cox's proportional hazard model. Age, serum total cholesterol, triglycerides, smoking and systolic blood pressure were all significant independent risk factors for coronary heart disease mortality in both sexes. Fasting blood sugar was of borderline significance, reaching sig- nificance among men, but not among women. However, since the women have much lower risk of dying from coronary heart disease than the men the absolute risk associated with each of the risk factors is much lower in the women. 114 Læknablaðið 2005/91
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
Page 53
Page 54
Page 55
Page 56
Page 57
Page 58
Page 59
Page 60
Page 61
Page 62
Page 63
Page 64
Page 65
Page 66
Page 67
Page 68
Page 69
Page 70
Page 71
Page 72
Page 73
Page 74
Page 75
Page 76
Page 77
Page 78
Page 79
Page 80
Page 81
Page 82
Page 83
Page 84
Page 85
Page 86
Page 87
Page 88
Page 89
Page 90
Page 91
Page 92
Page 93
Page 94
Page 95
Page 96
Page 97
Page 98
Page 99
Page 100
Page 101
Page 102
Page 103
Page 104
Page 105
Page 106
Page 107
Page 108
Page 109
Page 110
Page 111
Page 112
Page 113
Page 114
Page 115
Page 116
Page 117
Page 118
Page 119
Page 120
Page 121
Page 122
Page 123
Page 124
Page 125
Page 126
Page 127
Page 128
Page 129
Page 130
Page 131
Page 132
Page 133
Page 134
Page 135
Page 136
Page 137
Page 138
Page 139
Page 140

x

Læknablaðið

Direct Links

If you want to link to this newspaper/magazine, please use these links:

Link to this newspaper/magazine: Læknablaðið
https://timarit.is/publication/986

Link to this issue:

Link to this page:

Link to this article:

Please do not link directly to images or PDFs on Timarit.is as such URLs may change without warning. Please use the URLs provided above for linking to the website.